HNRNPK and amyotrophic lateral sclerosis: Overall, three independent patient-derived models provide convincing evidence for HNRNPK cytoplasmic mislocalization in C9 ALS/FTD, which further corroborates the implication of HNRNPK dysfunction in C9 ALS/FTD.